Application

TECELRA

Adaptimmune Limited

Trademark/Service Mark Application, Principal Register

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)

Trademark/Service Mark Application, Principal Register

Serial Number: 90452726
Filing Date: 01/07/2021

The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 90452726
MARK INFORMATION
*MARK TECELRA
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT TECELRA
MARK STATEMENT The mark consists of standard characters, without claim to any particular font style, size, or color.
REGISTER Principal
APPLICANT INFORMATION
*OWNER OF MARK Adaptimmune Limited
*MAILING ADDRESS 60 Jubilee Avenue, Milton Park, Abingdon
*CITY Oxford
*COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United Kingdom
*ZIP/POSTAL CODE
(Required for U.S. and certain international addresses)
OX144RX
*EMAIL ADDRESS XXXX
LEGAL ENTITY INFORMATION
TYPE limited company (ltd.)
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY WHERE LEGALLY ORGANIZED United Kingdom
GOODS AND/OR SERVICES AND BASIS INFORMATION
INTERNATIONAL CLASS 005 
*IDENTIFICATION Cell therapy pharmaceutical preparations; immunotherapy preparations; T-cell receptors; immunotherapy preparations comprising engineered T-cell receptors; immunotherapy preparations comprising genes encoding engineered T-cell receptors
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER 00003576004
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United Kingdom
       FOREIGN FILING DATE 01/07/2021
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
INTERNATIONAL CLASS 044 
*IDENTIFICATION Cell therapy medical treatment services; immunotherapy services; medical treatment and immune-therapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient
FILING BASIS SECTION 1(b)
FILING BASIS SECTION 44(d)
       FOREIGN APPLICATION NUMBER 00003576004
       FOREIGN APPLICATION
       COUNTRY/REGION/JURISDICTION/U.S. TERRITORY
United Kingdom
       FOREIGN FILING DATE 01/07/2021
       INTENT TO
       PERFECT 44(d)
At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.
ATTORNEY INFORMATION
NAME Christiane S. Campbell
ATTORNEY DOCKET NUMBER K0677-00073
ATTORNEY BAR MEMBERSHIP NUMBER XXX
YEAR OF ADMISSION XXXX
U.S. STATE/ COMMONWEALTH/ TERRITORY XX
FIRM NAME Duane Morris LLP
STREET 30 South 17th Street
CITY Philadelphia
STATE Pennsylvania
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP/POSTAL CODE 19103
PHONE 215-979-1817
FAX 215-979-1020
EMAIL ADDRESS ccampbell@duanemorris.com
OTHER APPOINTED ATTORNEY Karen Chuang Kline and All Duane Morris Attorneys
DOMESTIC REPRESENTATIVE INFORMATION
NAME Christiane S. Campbell
FIRM NAME Duane Morris LLP
STREET 30 South 17th Street
CITY Philadelphia
STATE Pennsylvania
COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
ZIP CODE 19103
PHONE 215-979-1817
FAX 215-979-1020
EMAIL ADDRESS ccampbell@duanemorris.com
CORRESPONDENCE INFORMATION
NAME Christiane S. Campbell
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE ccampbell@duanemorris.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) tdmkatlanta@duanemorris.com; ipdocketing@duanemorris.com
FEE INFORMATION
APPLICATION FILING OPTION TEAS Standard
NUMBER OF CLASSES 2
APPLICATION FOR REGISTRATION PER CLASS 350
*TOTAL FEES DUE 700
*TOTAL FEES PAID 700
SIGNATURE INFORMATION
SIGNATURE /Kerry Sharp/
SIGNATORY'S NAME Kerry Sharp
SIGNATORY'S POSITION General Counsel and IP Counsel
SIGNATORY'S PHONE NUMBER +44 7736 887238
DATE SIGNED 01/07/2021
SIGNATURE METHOD Sent to third party for signature



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1478 (Rev 09/2006)
OMB No. 0651-0009 (Exp 02/28/2021)


Trademark/Service Mark Application, Principal Register

Serial Number: 90452726
Filing Date: 01/07/2021

To the Commissioner for Trademarks:

MARK: TECELRA (Standard Characters, see mark)
The literal element of the mark consists of TECELRA. The mark consists of standard characters, without claim to any particular font style, size, or color.
The applicant, Adaptimmune Limited, a limited company (ltd.) legally organized under the laws of United Kingdom, having an address of
      60 Jubilee Avenue, Milton Park, Abingdon
      Oxford OX144RX
      United Kingdom
      XXXX

requests registration of the trademark/service mark identified above in the United States Patent and Trademark Office on the Principal Register established by the Act of July 5, 1946 (15 U.S.C. Section 1051 et seq.), as amended, for the following:

International Class 005:  Cell therapy pharmaceutical preparations; immunotherapy preparations; T-cell receptors; immunotherapy preparations comprising engineered T-cell receptors; immunotherapy preparations comprising genes encoding engineered T-cell receptors
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on United Kingdom application number 00003576004, filed 01/07/2021.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.


International Class 044:  Cell therapy medical treatment services; immunotherapy services; medical treatment and immune-therapy comprising harvesting a patient's white blood cells, combining white blood cells with an engineered T-cell receptor therapeutic, transducing the white blood cells with the gene encoding the engineered T-cell receptor and infusion of the transduced white blood cells back into the patient
Intent to Use: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services.

Priority based on foreign filing: The applicant has a bona fide intention, and is entitled, to use the mark in commerce on or in connection with the identified goods/services and asserts a claim of priority based on United Kingdom application number 00003576004, filed 01/07/2021.
INTENT TO PERFECT 44(d) : At this time, the applicant intends to rely on Section 44(e) as a basis for registration and requests that the application be suspended to await the submission of the foreign registration. If ultimately the applicant does not rely on §44(e) as a basis for registration, a valid claim of priority may be retained.




The owner's/holder's proposed attorney information: Christiane S. Campbell. Other appointed attorneys are Karen Chuang Kline and All Duane Morris Attorneys. Christiane S. Campbell of Duane Morris LLP, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, and the attorney(s) is located at
      30 South 17th Street
      Philadelphia, Pennsylvania 19103
      United States
      215-979-1817(phone)
      215-979-1020(fax)
      ccampbell@duanemorris.com
The docket/reference number is K0677-00073.
Christiane S. Campbell submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any U.S. Commonwealth or territory.

The applicant hereby appoints Christiane S. Campbell of Duane Morris LLP
      30 South 17th Street
      Philadelphia Pennsylvania 19103
      United States
      215-979-1817(phone)
      215-979-1020(fax)
      ccampbell@duanemorris.com
as applicant's representative upon whom notice or process in the proceedings affecting the mark may be served.

The applicant's current Correspondence Information:
      Christiane S. Campbell
       PRIMARY EMAIL FOR CORRESPONDENCE: ccampbell@duanemorris.com
       SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): tdmkatlanta@duanemorris.com; ipdocketing@duanemorris.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the applicant owner/holder and the applicant owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).
A fee payment in the amount of $700 has been submitted with the application, representing payment for 2 class(es).

Declaration

Declaration Signature

Signature: /Kerry Sharp/   Date: 01/07/2021
Signatory's Name: Kerry Sharp
Signatory's Position: General Counsel and IP Counsel
Signatory's Phone Number: +44 7736 887238
Signature method: Sent to third party for signature
Payment Sale Number: 90452726
Payment Accounting Date: 01/07/2021

Serial Number: 90452726
Internet Transmission Date: Thu Jan 07 13:15:55 ET 2021
TEAS Stamp: USPTO/BAS-XX.XXX.XXX.XXX-202101071315552
78023-90452726-76053a4c4af35dd7948e8444a
2fb690675edd9f18a2692db7e44429dfc02a849c
eb-DA-15542735-20210107105733474620

Application [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed